Functionally, loss of Treg cells secondary to Gpx4 ablation potentiated antitumor activity, establishing a critical role for Gpx4 in protecting intratumoral Treg and offering a novel therapeutic strategy to improve anti-cancer treatments (154). Here, GPX4 is linked to cancer.